At the American Academy of Ophthalmology, Iantrek Founder Dr. Sean Ianchulev shares his vision for the future of interventional glaucoma. Hear how Iantrek is pioneering Bio-Interventional Ophthalmic Surgery (BIOS) and leading the charge in unlocking the full potential of uveoscleral outflow.
Iantrek News | October 22, 2024
Charting a New Course in Ophthalmic Innovation


